Bionity.COM Newsletter No. 19/2010, 05/19/2010

New Products and Services

> more

Ultra-selective bacterial DNA enrichment
Up to 40.000 fold sensitivity increase
Ultra selective bacterial DNA isolation is now possible using MolYsis. PCR inhibitors and human DNA are removed concomitantly to highly pure bacterial DNA isolation resulting in reliable and sensitive PCR reactions...

http://www.bionity.com/products/e/117330/

Request information

High Performance Solvent Trapping...
The SpeedTrap^TM is a revolutionary cold trap developed by Genevac. The SpeedTrap^TM provides high performance solvent trapping having a high power compressor running at -50 ºC and is incredibly simple to use. All solvents collect in the insulated, plastic coated...

http://www.bionity.com/products/e/116161/

Request information

Uninterrupted Data Flow Between LIMS and Lab Instruments
The Workflow Manager Controls the Lab
Manz Automation AG's Workflow Manager is a laboratory control software solution that takes over these tasks. Processes can be flexibly configured and linked to the sample data. The Workflow Manager controls the generated tasks across all connected instruments...

http://www.bionity.com/products/e/100385/

Request information

Life Science loves Limsophy
New possibilities for the information management in your lab
AAC Infotray AG has developed a new product line which inspires people from Research and Analytics. Limsophy supports cross-departmental thinking and acting. "Philosophy of Limsophy" means integrated information management....

http://www.bionity.com/products/e/51678/

Request information

Licensed Endotoxin detection for the future
Endosafe-PTS is a rapid, point-of-use test system providing quantitative LAL results in about 15 minutes
The Endosafe-PTS utilizes LAL reagents in a disposable test cartridge with a handheld reader for a completely contained, real-time endotoxin testing system. This system is licensed by the FDA as testing method for in-process and final release testing of pharmaceutical products...

http://www.bionity.com/products/e/58128/

Request information

Innovative Viresolve^® Pro+ Solution from Millipore for Virus Safety
Viresolve Pro+ Solution strengthens Millipore's offerings by providing a robust and effective parvovirus clearance that works effectively at higher titer feedstreams...

http://www.bionity.com/products/e/114517/

Request information

eVol^® - World´s first hand-held automated analytical syringe
SGE, the pre-eminent manufacturer of analytical syringes has released the world's first fully automated analytical syringe: eVol^®. Combining an analytical syringe with a digital drive and control facility has created a cutting edge handheld analytical syringe that drives laboratory efficiency, precision and accuracy to new levels...

http://www.bionity.com/products/e/113257/

Request information

Biotech News

> more

Latest News from Biotechnology and Pharma from 05/12/2010 to 05/18/2010

Gene loss causes leukemia
05/18/2010 - Researchers from VIB and K.U.Leuven, both in Flanders, Belgium, have discovered a new factor in the development of acute lymphoblastic leukemia, a disease that mainly affects children. In the cells of...
http://www.bionity.com/news/e/117679/

Agilent Technologies Completes Acquisition of Varian, Inc.
05/18/2010 - Agilent Technologies Inc. announced that its acquisition of scientific-equipment maker Varian, Inc. is now final, positioning Agilent as a leading provider of analytical instrumentation to the applied...
http://www.bionity.com/news/e/117678/

Neovacs achieves significant milestones in two clinical trials
Successful completion of patient recruitment in the company's Phase I/II trial of TNFalpha-KinoidTM in Crohn's disease
05/18/2010 - Neovacs announced that it has recruited the last two patients into its Phase I/II clinical trial of anti-TNFalpha-KinoidTM (TNF-K) in Crohn's disease and has administered interferon-alpha KinoidTM (I...
http://www.bionity.com/news/e/117677/

Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co., Inc
05/18/2010 - ElexoPharm GmbH announced a collaboration and exclusive worldwide license agreement with Merck & Co., Inc. through an affiliate to develop and commercialize novel candidates targeting aldosterone synt...
http://www.bionity.com/news/e/117680/

OctoPlus appoint Susan Swarte to Executive Board and Nancy de Ruiter to Supervisory Board
05/18/2010 - OctoPlus N.V. announced that its Annual General Meeting of Shareholders has appointed Mrs. Susan Swarte to the Executive Board and has appointed Mrs. Nancy de Ruiter to the Supervisory Board.
Mrs....
http://www.bionity.com/news/e/117585/

Anti-inflammatory drugs can help block hypertension-related kidney damage
05/17/2010 - Anti-inflammatory drugs appear to help block the rapid kidney destruction that can occur with hypertension, Medical College of Georgia researchers report. Treating hypertensive rats with the broad-act...
http://www.bionity.com/news/e/117557/

GSK extends presence in Asia with new strategic alliance in South Korea
05/17/2010 - GlaxoSmithKline (GSK) entered into a strategic alliance with Dong-A Pharmaceuticals Co., Ltd. (Dong-A. As part of the transaction, GSK will acquire a 9.9 percent minority equity shareholding in Dong-...
http://www.bionity.com/news/e/117553/

caprotec bioanalytics Completes Series B Financing Round of EUR 4 Million
05/17/2010 - caprotec bioanalytics GmbH announced the closing of a EUR 4 million ($5.1M) Series B Financing Round with existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-kn...
http://www.bionity.com/news/e/117580/

Revealing the metabolic activity of microbial communities
05/17/2010 - Microbial communities are performing important functions all around us – from the earth in our flowerpots to the human gut. Now researchers have developed a method for studying the metabolic functions...
http://www.bionity.com/news/e/117558/

New details of tuberculosis protein-cleaving machinery revealed
Findings further understanding of how pathogen survives
05/17/2010 - Scientists looking for new ways to fight tuberculosis (TB) have their sights set on a structure essential to the bacterium's survival. Disabling this structure could kill the microbes in the infected ...
http://www.bionity.com/news/e/117559/

Enabling easy access to DNA sequence information
05/14/2010 - The European Nucleotide Archive (ENA) is launched, consolidating three major sequence resources to become Europe's primary access point to globally comprehensive DNA and RNA sequence information. The ...
http://www.bionity.com/news/e/117503/

Carl Zeiss Ltd. acquires Imaging Associates Ltd.
05/14/2010 - Carl Zeiss Ltd has agreed to acquire Imaging Associates Ltd. as part of its continuing investment into customer support and service delivery. Imaging Associates (IMAS) has been supporting digital imag...
http://www.bionity.com/news/e/117545/

Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms
'South-South' biotech collaborations boost health, economies: Study
05/14/2010 - The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech ...
http://www.bionity.com/news/e/117505/

Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial
05/14/2010 - Quest PharmaTech Inc. announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study wi...
http://www.bionity.com/news/e/117555/

Amorfix and Epitomics enter into agreement to develop novel monoclonal antibodies for the treatment of cancers
05/14/2010 - Amorfix Life Sciences and Epitomics, Inc. announced that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identifi...
http://www.bionity.com/news/e/117554/

Scientists design new drug type to kill lymphoma cells
05/12/2010 - Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The...
http://www.bionity.com/news/e/117502/

Merck Settles Patent Infringement Case for Zetia (ezetimibe)
05/12/2010 - Merck & Co., Inc. and Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals, Ltd. have reached an agreement to settle their patent litigation involving Glenmark's challenge to Merck's patent...
http://www.bionity.com/news/e/117499/

Cipher achieves major milestone with FDA approval for CIP-TRAMADOL ER
05/12/2010 - Cipher Pharmaceuticals Inc. announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately s...
http://www.bionity.com/news/e/117500/

Ferring Acquires LYSTEDA From Xanodyne Pharmaceuticals, Inc.
05/12/2010 - Ferring Pharmaceuticals announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA™ (tranexamic acid), ...
http://www.bionity.com/news/e/117492/

Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
05/12/2010 - Fate Therapeutics, Inc. announced the appointment of Tom Novak, Ph.D., as vice president of research and drug discovery. Dr. Novak brings to Fate more than 15 years of experience working with large ph...
http://www.bionity.com/news/e/117501/

Events

> more

Events, Workshops and Training Courses